Trials / Completed
CompletedNCT00609193
Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
Functional and Neurochemical Brain Changes in First-episode Bipolar Mania Following Successful Treatment With Lithium or Quetiapine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to use magnetic resonance imaging (MRI) to examine brain structure, function and chemistry in people with bipolar disorder who are being treated with either quetiapine or lithium. Both of these medicines are FDA-approved to treat mania in adults and lithium is also FDA approved in children; quetiapine is commonly used in children with mania, but is not FDA approved for this indication in this age group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lithium | standard clinical care |
| DRUG | quetiapine | standard clinical care |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2008-02-06
- Last updated
- 2015-12-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00609193. Inclusion in this directory is not an endorsement.